Trial intelligence / Profile preview

Propofol-ketamine versus thiopental-fentanyl for adult procedural sedation and analgesia

IRCT2015111325025N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jan 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of propofol, ketamine, thiopental and fentanyl in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Sedation efficacy. Started Jan 2016; status: completed.

02

Drugs

propofolketaminethiopentalfentanyl

Beyond the preview

Go deeper on IRCT2015111325025N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015111325025N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call